Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program.

Pitter G, Da Re F, Canova C, Barbieri G, Zare Jeddi M, Daprà F, Manea F, Zolin R, Bettega AM, Stopazzolo G, Vittorii S, Zambelli L, Martuzzi M, Mantoan D, Russo F.

Environ Health Perspect. 2020 Feb;128(2):27007. doi: 10.1289/EHP5337. Epub 2020 Feb 18.

2.

The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation.

Corti R, Cox A, Cassina V, Nardo L, Salerno D, Marrano CA, Missana N, Andreozzi P, Silva PJ, Stellacci F, Dal Magro R, Re F, Mantegazza F.

Int J Mol Sci. 2020 Feb 5;21(3). pii: E1066. doi: 10.3390/ijms21031066.

3.

High rate selection of PHA accumulating mixed cultures in sequencing batch reactors with uncoupled carbon and nitrogen feeding.

Lorini L, di Re F, Majone M, Valentino F.

N Biotechnol. 2020 Feb 1;56:140-148. doi: 10.1016/j.nbt.2020.01.006. [Epub ahead of print]

PMID:
32017996
4.

Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility.

Montefusco-Pereira CV, Formicola B, Goes A, Re F, Marrano CA, Mantegazza F, Carvalho-Wodarz C, Fuhrmann G, Caneva E, Nicotra F, Lehr CM, Russo L.

Eur J Pharm Biopharm. 2020 Jan 30. pii: S0939-6411(20)30024-2. doi: 10.1016/j.ejpb.2020.01.013. [Epub ahead of print]

5.

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2).

Mauro FR, Molica S, Soddu S, Ilariucci F, Coscia M, Zaja F, Angelucci E, Re F, Liberati AM, Tedeschi A, Reda G, Pietrasanta D, Gozzetti A, Battistini R, Del Poeta G, Musolino C, Nanni M, Piciocchi A, Vignetti M, Neri A, Albano F, Cuneo A, Del Giudice I, Della Starza I, De Propris MS, Raponi S, Guarini AR, Foà R.

Haematologica. 2020 Jan 30. pii: haematol.2019.235705. doi: 10.3324/haematol.2019.235705. [Epub ahead of print] No abstract available.

6.

Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study.

Re GL, Santeufemia DA, Re FL, Bortolus R, Doretto P, Marus W, Buttazzi L, Lenardon O, Falda A, Piazza R, Sulfaro S.

Cytokine. 2020 Apr;128:154984. doi: 10.1016/j.cyto.2019.154984. Epub 2020 Jan 20.

PMID:
31972343
7.

Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes.

Formicola B, D'Aloia A, Dal Magro R, Stucchi S, Rigolio R, Ceriani M, Re F.

Front Bioeng Biotechnol. 2019 Dec 12;7:403. doi: 10.3389/fbioe.2019.00403. eCollection 2019.

8.

Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction.

Salvioni E, Corrà U, Piepoli M, Rovai S, Correale M, Paolillo S, Pasquali M, Magrì D, Vitale G, Fusini L, Mapelli M, Vignati C, Lagioia R, Raimondo R, Sinagra G, Boggio F, Cangiano L, Gallo G, Magini A, Contini M, Palermo P, Apostolo A, Pezzuto B, Bonomi A, Scardovi AB, Filardi PP, Limongelli G, Metra M, Scrutinio D, Emdin M, Piccioli L, Lombardi C, Cattadori G, Parati G, Caravita S, Re F, Cicoira M, Frigerio M, Clemenza F, Bussotti M, Battaia E, Guazzi M, Bandera F, Badagliacca R, Di Lenarda A, Pacileo G, Passino C, Sciomer S, Ambrosio G, Agostoni P; MECKI score research group.

ESC Heart Fail. 2020 Jan 1. doi: 10.1002/ehf2.12582. [Epub ahead of print]

9.

Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group.

Piepoli MF, Salvioni E, Corrà U, Doni F, Bonomi A, La Gioia R, Limongelli G, Paolillo S, Sinagra G, Scardovi AB, Raimondo R, Emdin M, Re F, Cicoira M, Correale M, Badagliacca R, Clemenza F, Lombardi C, Agostoni P.

Eur J Intern Med. 2019 Nov 28. pii: S0953-6205(19)30390-5. doi: 10.1016/j.ejim.2019.11.003. [Epub ahead of print]

PMID:
31787490
10.

Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.

Rovai S, Corrà U, Piepoli M, Vignati C, Salvioni E, Bonomi A, Mattavelli I, Arcari L, Scardovi AB, Perrone Filardi P, Lagioia R, Paolillo S, Magrì D, Limongelli G, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Lombardi C, Cattadori G, Parati G, Re F, Cicoira M, Villani GQ, Minà C, Correale M, Frigerio M, Perna E, Mapelli M, Magini A, Clemenza F, Bussotti M, Battaia E, Guazzi M, Bandera F, Badagliacca R, Di Lenarda A, Pacileo G, Maggioni A, Passino C, Sciomer S, Sinagra G, Agostoni P; MECKI Score Research Group (see Appendix 1).

Eur J Heart Fail. 2019 Dec;21(12):1586-1595. doi: 10.1002/ejhf.1595. Epub 2019 Nov 28.

PMID:
31782225
11.

The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB.

Formicola B, Dal Magro R, Montefusco-Pereira CV, Lehr CM, Koch M, Russo L, Grasso G, Deriu MA, Danani A, Bourdoulous S, Re F.

J Nanobiotechnology. 2019 Nov 11;17(1):115. doi: 10.1186/s12951-019-0546-3.

12.

[A case of right atrial high grade angiosarcoma presenting with pulmonary embolism and cardiac tamponade].

Terlizzese G, Del Re F, Pucci A, Pedrinelli R.

G Ital Cardiol (Rome). 2019 Nov;20(11):664-667. doi: 10.1714/3254.32228. Italian.

PMID:
31697274
13.

Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia.

Bernardi S, Foroni C, Zanaglio C, Re F, Polverelli N, Turra A, Morello E, Farina M, Cattina F, Gandolfi L, Zollner T, Buttini EA, Malagola M, Russo D.

Int J Mol Med. 2019 Dec;44(6):2133-2144. doi: 10.3892/ijmm.2019.4372. Epub 2019 Oct 14.

14.

Nanomedicine for the Treatment of Alzheimer's Disease.

Formicola B, Cox A, Dal Magro R, Masserini M, Re F.

J Biomed Nanotechnol. 2019 Oct 1;15(10):1997-2024. doi: 10.1166/jbn.2019.2837. Review.

PMID:
31462368
15.

Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.

Todiere G, Nugara C, Gentile G, Negri F, Bianco F, Falletta C, Novo G, Di Bella G, De Caterina R, Zachara E, Re F, Clemenza F, Sinagra G, Emdin M, Aquaro GD.

Am J Cardiol. 2019 Oct 15;124(8):1286-1292. doi: 10.1016/j.amjcard.2019.07.023. Epub 2019 Jul 29.

PMID:
31447011
16.

Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells.

Prezioso L, Manfra I, Bonomini S, Schifano C, Segreto R, Monti A, Sammarelli G, Todaro G, Sassi M, Bertaggia I, Pelagatti L, Cambò B, Spolzino A, Follini E, Re F, Crugnola M, Craviotto L, Russo F, Plenteda C, Roti G, Giuliani N, Aversa F.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):698-702. doi: 10.1038/s41409-019-0608-z.

PMID:
31431717
17.

Non-invasive prediction of genotype positive-phenotype negative in hypertrophic cardiomyopathy by 3D modern shape analysis.

Piras P, Torromeo C, Evangelista A, Esposito G, Nardinocchi P, Teresi L, Madeo A, Re F, Chialastri C, Schiariti M, Varano V, Puddu PE.

Exp Physiol. 2019 Nov;104(11):1688-1700. doi: 10.1113/EP087551. Epub 2019 Sep 1.

PMID:
31424582
18.

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer.

Bearz A, Cecco S, Francescon S, Re FL, Corona G, Baldo P.

Recent Pat Anticancer Drug Discov. 2019;14(3):242-257. doi: 10.2174/1574892814666190726124735.

PMID:
31362665
19.

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma.

Basile D, Lisanti C, Pizzichetta MA, Baldo P, Fornasier G, Lo Re F, Corona G, Puglisi F.

Recent Pat Anticancer Drug Discov. 2019;14(3):203-225. doi: 10.2174/1574892814666190726130351.

PMID:
31362664
20.

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer.

Vaccher E, Schioppa O, Martellotta F, Fornasier G, Giacomin E, Re FL, Baldo P, Corona G, Gobitti C.

Recent Pat Anticancer Drug Discov. 2019;14(3):226-241. doi: 10.2174/1574892814666190726143011.

PMID:
31362663
21.

Chitosan-based scaffold counteracts hypertrophic and fibrotic markers in chondrogenic differentiated mesenchymal stromal cells.

Manferdini C, Gabusi E, Sartore L, Dey K, Agnelli S, Almici C, Bianchetti A, Zini N, Russo D, Re F, Mariani E, Lisignoli G.

J Tissue Eng Regen Med. 2019 Oct;13(10):1896-1911. doi: 10.1002/term.2941. Epub 2019 Aug 20.

PMID:
31348588
22.

Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation.

Dey K, Agnelli S, Re F, Russo D, Lisignoli G, Manferdini C, Bernardi S, Gabusi E, Sartore L.

Macromol Biosci. 2019 Aug;19(8):e1900099. doi: 10.1002/mabi.201900099. Epub 2019 Jul 12.

PMID:
31298816
23.

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.

Luminari S, Merli M, Rattotti S, Tarantino V, Marcheselli L, Cavallo F, Varettoni M, Bianchi B, Merli F, Tedeschi A, Cabras G, Re F, Visco C, Torresan Delamain M, Cencini E, Spina M, Ferrero S, Ferrari A, Deodato M, Mannina D, Annibali O, Rago A, Orsucci L, Defrancesco I, Frigeni M, Cesaretti M, Arcaini L.

Blood. 2019 Sep 5;134(10):798-801. doi: 10.1182/blood.2019001088. Epub 2019 Jul 10.

PMID:
31292118
24.

Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier.

Cox A, Vinciguerra D, Re F, Magro RD, Mura S, Masserini M, Couvreur P, Nicolas J.

Eur J Pharm Biopharm. 2019 Sep;142:70-82. doi: 10.1016/j.ejpb.2019.06.004. Epub 2019 Jun 6.

25.

The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro.

Dal Magro R, Simonelli S, Cox A, Formicola B, Corti R, Cassina V, Nardo L, Mantegazza F, Salerno D, Grasso G, Deriu MA, Danani A, Calabresi L, Re F.

Front Neurosci. 2019 May 16;13:419. doi: 10.3389/fnins.2019.00419. eCollection 2019.

26.

Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.

Phillips JS, Da Re F, Irwin DJ, McMillan CT, Vaishnavi SN, Xie SX, Lee EB, Cook PA, Gee JC, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M.

Brain. 2019 Jun 1;142(6):1701-1722. doi: 10.1093/brain/awz091.

PMID:
31135048
27.

The "Patient's Empowerment rights-duty Charter": new communication tools targeted at patient and professionals in a Hematology and Bone marrow transplant center.

Mengozzi C, Campaniello G, Aversa F, Re F, Calatafimi B, Albertini R, Montali F.

Acta Biomed. 2019 May 23;90(2):233-240. doi: 10.23750/abm.v90i2.6831.

28.

3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation.

Re F, Sartore L, Moulisova V, Cantini M, Almici C, Bianchetti A, Chinello C, Dey K, Agnelli S, Manferdini C, Bernardi S, Lopomo NF, Sardini E, Borsani E, Rodella LF, Savoldi F, Paganelli C, Guizzi P, Lisignoli G, Magni F, Salmeron-Sanchez M, Russo D.

J Tissue Eng. 2019 May 2;10:2041731419845852. doi: 10.1177/2041731419845852. eCollection 2019 Jan-Dec.

29.

Acute intraventricular migration of a transcatheter aortic prosthesis.

Re FD, Pascarella C, Pratali S, Celiento M, Bortolotti U.

Asian Cardiovasc Thorac Ann. 2019 Nov;27(9):764-766. doi: 10.1177/0218492319851401. Epub 2019 May 14. No abstract available.

PMID:
31088109
30.

Gasdermin D Protects from Melioidosis through Pyroptosis and Direct Killing of Bacteria.

Wang J, Deobald K, Re F.

J Immunol. 2019 Jun 15;202(12):3468-3473. doi: 10.4049/jimmunol.1900045. Epub 2019 Apr 29.

PMID:
31036765
31.

Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin.

Palazzolo S, Hadla M, Spena CR, Bayda S, Kumar V, Lo Re F, Adeel M, Caligiuri I, Romano F, Corona G, Canzonieri V, Toffoli G, Rizzolio F.

ACS Med Chem Lett. 2019 Jan 31;10(4):517-521. doi: 10.1021/acsmedchemlett.8b00557. eCollection 2019 Apr 11.

PMID:
30996789
32.

A New Approach for Glyco-Functionalization of Collagen-Based Biomaterials.

Figuereido I, Paiotta A, Dal Magro R, Tinelli F, Corti R, Re F, Cassina V, Caneva E, Nicotra F, Russo L.

Int J Mol Sci. 2019 Apr 9;20(7). pii: E1747. doi: 10.3390/ijms20071747.

33.

Syphilitic Aortic Aneurysm in the Third Millennium.

Del Re F, Falcetta GS, Pratali S, Belgio B, Pucci A, Bortolotti U.

Aorta (Stamford). 2018 Oct;6(5):118-119. doi: 10.1055/s-0039-1683399. Epub 2019 Apr 1.

34.

Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement.

Perli E, Pisano A, Glasgow RIC, Carbo M, Hardy SA, Falkous G, He L, Cerbelli B, Pignataro MG, Zacara E, Re F, Della Monica PL, Morea V, Bonnen PE, Taylor RW, d'Amati G, Giordano C.

Sci Rep. 2019 Mar 25;9(1):5108. doi: 10.1038/s41598-019-41483-9.

35.

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.

Leonard JP, Trneny M, Izutsu K, Fowler NH, Hong X, Zhu J, Zhang H, Offner F, Scheliga A, Nowakowski GS, Pinto A, Re F, Fogliatto LM, Scheinberg P, Flinn IW, Moreira C, Cabeçadas J, Liu D, Kalambakas S, Fustier P, Wu C, Gribben JG; AUGMENT Trial Investigators.

J Clin Oncol. 2019 May 10;37(14):1188-1199. doi: 10.1200/JCO.19.00010. Epub 2019 Mar 21.

PMID:
30897038
36.

Hairy cell leukaemia mimicking multiple myeloma.

Notarfranchi L, Russo F, Re F, Mancini C, Martella E, Falini B, Aversa F, Tiacci E.

Lancet Oncol. 2019 Mar;20(3):e187. doi: 10.1016/S1470-2045(18)30609-0. No abstract available.

PMID:
30842062
37.

Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.

Paolillo S, Veglia F, Salvioni E, Corrà U, Piepoli M, Lagioia R, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Bonomi A, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Correale M, Frigerio M, Bussotti M, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Clemenza F, Binno S, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group (see Appendix).

Eur J Heart Fail. 2019 Feb;21(2):208-217. doi: 10.1002/ejhf.1364. Epub 2019 Jan 11.

38.

The Functional Meaning of B-Profile During Stress Lung Ultrasound.

Scali MC, Zagatina A, Ciampi Q, Cortigiani L, D'Andrea A, Djordjevic-Dikic A, Merlo PM, Lattanzi F, Simova I, Monte I, Dodi C, Kasprzak JD, Galderisi M, Boshchenko A, Rigo F, Varga A, Dekleva M, Re F, de Castro E Silva Pretto JL, Zhuravaskaya N, Wierzbowska-Drabik K, Coviello K, Citro R, Colonna P, Carpeggiani C, Picano E; Stress Echo 2020 Study Group of the Italian Society of Cardiovascular Imaging.

JACC Cardiovasc Imaging. 2019 May;12(5):928-930. doi: 10.1016/j.jcmg.2018.10.017. Epub 2018 Dec 12. No abstract available.

PMID:
30553657
39.

Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature.

Serra W, Fantin A, Longo C, Rabia G, De Rosa F, Plenteda C, Re F, Crisafulli E, Chetta A.

Cardiovasc Hematol Disord Drug Targets. 2019;19(3):253-258. doi: 10.2174/1871529X19666181205100705.

PMID:
30516116
40.

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C.

Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8.

PMID:
30407629
41.

Phage-displayed peptides targeting specific tissues and organs.

Andrieu J, Re F, Russo L, Nicotra F.

J Drug Target. 2019 Jun - Jul;27(5-6):555-565. doi: 10.1080/1061186X.2018.1531419. Epub 2018 Oct 24.

PMID:
30281393
42.

Quality control of B-lines analysis in stress Echo 2020.

Scali MC, Ciampi Q, Picano E, Bossone E, Ferrara F, Citro R, Colonna P, Costantino MF, Cortigiani L, Andrea A, Severino S, Dodi C, Gaibazzi N, Galderisi M, Barbieri A, Monte I, Mori F, Reisenhofer B, Re F, Rigo F, Trambaiolo P, Amor M, Lowenstein J, Merlo PM, Daros CB, de Castro E Silva Pretto JL, Miglioranza MH, Torres MAR, de Azevedo Bellagamba CC, Chaves DQ, Simova I, Varga A, Čelutkienė J, Kasprzak JD, Wierzbowska-Drabik K, Lipiec P, Weiner-Mik P, Szymczyk E, Wdowiak-Okrojek K, Djordjevic-Dikic A, Dekleva M, Stankovic I, Neskovic AN, Zagatina A, Di Salvo G, Perez JE, Camarozano AC, Corciu AI, Boshchenko A, Lattanzi F, Cotrim C, Fazendas P, Haberka M, Sobkowic B, Kosmala W, Witkowski T, Gosciniak P, Salustri A, Rodriguez-Zanella H, Leal LIM, Nikolic A, Gligorova S, Urluescu ML, Fiorino M, Novo G, Preradovic-Kovacevic T, Ostojic M, Beleslin B, Villari B, De Nes M, Paterni M, Carpeggiani C; Stress Echo 2020 study group of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI).

Cardiovasc Ultrasound. 2018 Sep 25;16(1):20. doi: 10.1186/s12947-018-0138-7.

43.

Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.

Campodonico J, Piepoli M, Clemenza F, Bonomi A, Paolillo S, Salvioni E, Corrà U, Binno S, Veglia F, Lagioia R, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Limongelli G, Correale M, Frigerio M, Bussotti M, Perna E, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group.

Int J Cardiol. 2018 Dec 15;273:141-146. doi: 10.1016/j.ijcard.2018.08.012. Epub 2018 Aug 6.

PMID:
30098827
44.

Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.

Magri D, Agostoni P, Sinagra G, Re F, Correale M, Limongelli G, Zachara E, Mastromarino V, Santolamazza C, Casenghi M, Pacileo G, Valente F, Morosin M, Musumeci B, Pagannone E, Maruotti A, Uguccioni M, Volpe M, Autore C.

Int J Cardiol. 2018 Nov 15;271:125-131. doi: 10.1016/j.ijcard.2018.04.019. Epub 2018 Aug 4.

PMID:
30087038
45.

Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.

Binda A, Panariti A, Barbuti A, Murano C, Dal Magro R, Masserini M, Re F, Rivolta I.

Int J Nanomedicine. 2018 Jul 11;13:4059-4071. doi: 10.2147/IJN.S161563. eCollection 2018.

46.

Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience.

Lo Re G, Lo Re F, Doretto P, Del Conte A, Amadio M, Cozzi C, Casarotto MM, Maruzzi D, Marus W, Ubiali P, Sandri P.

Cytokine. 2019 Jan;113:50-60. doi: 10.1016/j.cyto.2018.06.005. Epub 2018 Jun 27.

47.

Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier.

Cox A, Andreozzi P, Dal Magro R, Fiordaliso F, Corbelli A, Talamini L, Chinello C, Raimondo F, Magni F, Tringali M, Krol S, Jacob Silva P, Stellacci F, Masserini M, Re F.

ACS Nano. 2018 Jul 24;12(7):7292-7300. doi: 10.1021/acsnano.8b03500. Epub 2018 Jul 2.

PMID:
29953205
48.

Caspase-11-dependent pyroptosis of lung epithelial cells protects from melioidosis while caspase-1 mediates macrophage pyroptosis and production of IL-18.

Wang J, Sahoo M, Lantier L, Warawa J, Cordero H, Deobald K, Re F.

PLoS Pathog. 2018 May 23;14(5):e1007105. doi: 10.1371/journal.ppat.1007105. eCollection 2018 May.

49.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.

Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

50.

Surgical Treatment of Annuloaortic Ectasia - Replace or Repair?

Martino A, Re FD, Blasi S, Celiento M, Ravenni G, Pratali S, Milano AD, Bortolotti U.

Aorta (Stamford). 2017 Oct 1;5(5):139-147. doi: 10.12945/j.aorta.2017.17.044. eCollection 2017 Oct.

Supplemental Content

Support Center